Last reviewed · How we verify
Blood samples collect
Blood samples collect is a Biologic drug developed by Biocodex. It is currently in Phase 3 development for Diagnosis and monitoring of various diseases, including infections, anemia, and other conditions.
Blood samples collection involves the process of obtaining and analyzing blood from patients to diagnose and monitor diseases.
Blood samples are collected for various studies, including those on healthy volunteers, anticoagulant therapy, hematopoietic cell transplantation, mucopolysaccharidosis type I, and HIV infections. The samples are typically collected as whole blood, which is defined by its composition of all blood components, including red blood cells, plasma, and other cellular elements.
-
Baseline phase 3 → approval rate
+58.3pp
Industry-wide phase 3 drugs reach approval ~58.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2028–2030 | — |
| EMA | EU | 2029–2031 | +0.7 yr |
| MHRA | GB | 2029–2031 | +0.7 yr |
| Health Canada | CA | 2029–2032 | +0.9 yr |
| TGA | AU | 2029–2032 | +1.2 yr |
| PMDA | JP | 2029–2032 | +1.5 yr |
| NMPA | CN | 2030–2033 | +2.3 yr |
| MFDS | KR | 2029–2032 | +1.4 yr |
| CDSCO | IN | 2029–2033 | +1.8 yr |
| ANVISA | BR | 2030–2033 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Blood samples collect |
|---|---|
| Sponsor | Biocodex |
| Modality | Biologic |
| Therapeutic area | Diagnostics |
| Phase | Phase 3 |
Mechanism of action
This process typically involves drawing blood from a vein in the arm or other locations, and then analyzing the blood components to identify any abnormalities or changes that may indicate a disease or condition. The collected blood samples are then used to diagnose and monitor various diseases, including infections, anemia, and other conditions.
Approved indications
- Diagnosis and monitoring of various diseases, including infections, anemia, and other conditions
Common side effects
Key clinical trials
- Epigenetic Regulation of Human Adipose Tissue Distribution (NA)
- The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer (PHASE1)
- User Evaluation of a Home-collection Kit for People With Diabetes
- Construction and Evaluation of Tumor Immunotherapy and Organ Damage Early Warning System Based on Multi-omics
- Oral Aromatase Inhibitors Modify the Gut Microbiome
- Polyphenol Metabotypes in People With Diabetes Type 2
- Improving Exercise Capacity With a Tailored Physical Activity Intervention (NA)
- Prediction of Hyperkalemia in Dialysis Patients Through Waveform Analysis Using Wearable ECG
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Blood samples collect CI brief — competitive landscape report
- Blood samples collect updates RSS · CI watch RSS
- Biocodex portfolio CI
Frequently asked questions about Blood samples collect
What is Blood samples collect?
How does Blood samples collect work?
What is Blood samples collect used for?
Who makes Blood samples collect?
What development phase is Blood samples collect in?
Related
- Manufacturer: Biocodex — full pipeline
- Therapeutic area: All drugs in Diagnostics
- Indication: Drugs for Diagnosis and monitoring of various diseases, including infections, anemia, and other conditions
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing